Veterinary Medicine Teaching and Research Center, University of California, Davis School of Veterinary Medicine, Tulare, California, United States of America.
Department of Population Health and Reproduction, University of California, Davis School of Veterinary Medicine, Davis, California, United States of America.
PLoS One. 2019 Jul 10;14(7):e0219321. doi: 10.1371/journal.pone.0219321. eCollection 2019.
The objective of this clinical trial was to evaluate the effectiveness of zinc supplementation on diarrhea and average daily weight gain (ADG) in pre-weaned dairy calves. A total of 1,482 healthy Holstein heifer and bull calves from a large California dairy were enrolled at 24 to 48 hours of age until hutch exit at approximately 90 days of age. Calves were block-randomized by time to one of three treatments: 1) placebo, 2) zinc methionine (ZM), or 3) zinc sulfate (ZS) administered in milk once daily for 14 days. Serum total protein at enrollment and body weight at birth, treatment end, and hutch exit were measured. Fecal consistency was assessed daily for 28 days post-enrollment. For a random sample of 127 calves, serum zinc concentrations before and after treatment and a fecal antigen ELISA at diarrhea start and resolution for Escherichia coli K99, rotavirus, coronavirus, and Cryptosporidium parvum were performed. Linear regression showed that ZM-treated bull calves had 22 g increased ADG compared to placebo-treated bulls (P = 0.042). ZM-treated heifers had 9 g decreased ADG compared to placebo-treated heifers (P = 0.037), after adjusting for average birth weight. Sex-stratified models showed that high birth weight heifers treated with ZM gained more than placebo-treated heifers of the same birth weight, which suggests a dose-response effect rather than a true sex-specific effect of ZM on ADG. Cox regression showed that ZM and ZS-treated calves had a 14.7% (P = 0.015) and 13.9% (P = 0.022) reduced hazard of diarrhea, respectively, compared to placebo-treated calves. Calves supplemented for at least the first five days of diarrhea with ZM and ZS had a 21.4% (P = 0.027) and 13.0% (P = 0.040) increased hazard of cure from diarrhea, respectively, compared to placebo-treated calves. Logistic regression showed that the odds of microbiological cure at diarrhea resolution for rotavirus, C. parvum, or any single fecal pathogen was not different between treatment groups. Zinc supplementation delayed diarrhea and expedited diarrhea recovery in pre-weaned calves. Additionally, zinc improved weight gain differentially in bulls compared to heifers, indicating a research need for sex-specific dosing.
本临床试验的目的是评估补锌对哺乳期前奶牛腹泻和平均日增重(ADG)的影响。共招募了来自加利福尼亚州一个大型奶牛场的 1482 头健康的荷斯坦小母牛和公牛犊,它们在出生后 24 至 48 小时内接受了治疗,直到大约 90 日龄离开畜栏。根据时间,小牛被随机分为三组之一:1)安慰剂,2)锌蛋氨酸(ZM),或 3)硫酸锌(ZS),每日在牛奶中一次给药 14 天。在入组时和出生时、治疗结束时和畜栏离开时测量血清总蛋白,在入组后 28 天内每天评估粪便稠度。对 127 头小牛的随机样本进行了血清锌浓度测定,以及在腹泻开始和解决时的粪便抗原 ELISA 检测,用于检测大肠杆菌 K99、轮状病毒、冠状病毒和微小隐孢子虫。线性回归显示,与安慰剂组公牛相比,ZM 处理的公牛犊 ADG 增加了 22 克(P = 0.042)。ZM 处理的小母牛与安慰剂处理的小母牛相比,ADG 降低了 9 克(P = 0.037),但经过平均出生体重调整后。性别分层模型显示,高出生体重的 ZM 处理小母牛比相同出生体重的安慰剂处理小母牛增重更多,这表明 ZM 对 ADG 的影响存在剂量反应,而不是真正的性别特异性影响。Cox 回归显示,与安慰剂组相比,ZM 和 ZS 处理的小牛腹泻的风险分别降低了 14.7%(P = 0.015)和 13.9%(P = 0.022)。在腹泻的前 5 天内至少接受 ZM 和 ZS 补充治疗的小牛,腹泻治愈率分别提高了 21.4%(P = 0.027)和 13.0%(P = 0.040),与安慰剂组相比。逻辑回归显示,在腹泻缓解时,轮状病毒、微小隐孢子虫或任何单一粪便病原体的微生物学治愈率在治疗组之间没有差异。补锌可延迟哺乳期前小牛腹泻的发生并加快腹泻的恢复。此外,锌对公牛的增重效果优于小母牛,表明需要针对不同性别进行剂量研究。